Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH Market Vectors Pharmaceutical ETF

  • Fund Description

    Market Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors U.S., Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/09/16

    • 30-Day SEC Yield1

      2.05%
    • Total Net Assets

      $333.3M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2016
  • Portfolio Composition (%)
    as of 02/09/16

    • % of Net Assets
    • Stocks

      100.18
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.18
  • Download All HoldingsDaily Holdings (%) as of 02/09/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    277,743
    28,321,4548.50
    Novartis Ag
    NVS US
    311,314
    22,607,6236.78
    Glaxosmithkline Plc
    GSK US
    471,860
    18,562,9725.57
    Pfizer Inc
    PFE US
    627,195
    18,251,3755.48
    Merck & Co Inc
    MRK US
    353,850
    17,395,2665.22
    Sanofi
    SNY US
    442,480
    17,199,1985.16
    Bristol-Myers Squibb Co
    BMY US
    272,613
    16,634,8454.99
    Allergan Plc
    AGN US
    60,998
    16,612,1954.98
    Abbvie Inc
    ABBV US
    300,220
    16,055,7664.82
    Novo Nordisk A/S
    NVO US
    329,288
    15,338,2354.60
    Teva Pharmaceutical Industries Ltd
    TEVA US
    256,971
    14,819,5184.45
    Eli Lilly & Co
    LLY US
    200,588
    14,791,3594.44
    Astrazeneca Plc
    AZN US
    502,730
    14,373,0514.31
    Abbott Laboratories
    ABT US
    374,140
    13,843,1804.15
    Valeant Pharmaceuticals International I
    VRX US
    157,657
    13,708,2764.11
    Mckesson Corp
    MCK US
    89,925
    13,522,9224.06
    Shire Plc
    SHPG US
    84,978
    12,850,3733.86
    Perrigo Co
    PRGO US
    74,187
    10,294,9303.09
    Mylan Inc/Pa
    MYL US
    199,928
    10,144,3473.04
    Zoetis Inc
    ZTS US
    234,710
    9,355,5412.81
    Amerisourcebergen Corp
    ABC US
    95,720
    8,112,2702.43
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    85,395
    4,459,3271.34
    Mallinckrodt Plc
    MNK US
    48,506
    3,056,3630.92
    Jazz Pharmaceuticals Plc
    JAZZ US
    21,379
    2,494,9290.75
    Akorn Inc
    AKRX US
    44,304
    1,086,3340.33
    Other/Cash
    --
    --
    -599,175-0.18
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.